Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
Titel:
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
Auteur:
Poeschel, Viola Held, Gerhard Ziepert, Marita Witzens-Harig, Mathias Holte, Harald Thurner, Lorenz Borchmann, Peter Viardot, Andreas Soekler, Martin Keller, Ulrich Schmidt, Christian Truemper, Lorenz Mahlberg, Rolf Marks, Reinhard Hoeffkes, Heinz-Gert Metzner, Bernd Dierlamm, Judith Frickhofen, Norbert Haenel, Mathias Neubauer, Andreas Kneba, Michael Merli, Francesco Tucci, Alessandra de Nully Brown, Peter Federico, Massimo Lengfelder, Eva di Rocco, Alice Trappe, Ralf Rosenwald, Andreas Berdel, Christian Maisenhoelder, Martin Shpilberg, Ofer Amam, Josif Christofyllakis, Konstantinos Hartmann, Frank Murawski, Niels Stilgenbauer, Stephan Nickelsen, Maike Wulf, Gerald Glass, Bertram Schmitz, Norbert Altmann, Bettina Loeffler, Markus Pfreundschuh, Michael